Adam Driesman, MD
Orthopaedic Surgery · Fairfield, CTNPI 1881128379
Payments from drug & device makers
Across 101 payments — averaging $100.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$3K
- Medacta USA, Inc.$3K
- Omnilife Science, Inc$2K
- Smith+Nephew$2K
- Johnson & Johnson$213
- Medtronic$153
- plus $331 from 7 others
What the payments were for
- Travel & lodging$5,45954%
- Food & beverage$4,64146%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 25 | $2,966 |
| Medacta USA, Inc. | 19 | $2,926 |
| Omnilife Science, Inc | 17 | $1,769 |
| Smith+Nephew | 25 | $1,742 |
| Johnson & Johnson | 5 | $213 |
| Medtronic | 1 | $153 |
| Pacira Pharmaceuticals Incorporated | 2 | $150 |
| Vertex | 2 | $64 |
| Nuvasive Specialized Orthopedics, Inc. | 1 | $35 |
| Avanos Medical | 1 | $30 |
| Innovation Technologies Inc | 1 | $22 |
| Medical Device Business Services, Inc. | 1 | $17 |
| Davol Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MAKO$1,949
- OMNIBotics 3.0$1,500
- AMISTEM$932
- GMK Sphere Revision System$920
- GMK SPHERE$509
- Journey II$471
- REAL INTELLIGENCE$458
- Legion$341
- T2 ALPHA$175
- VARIAX$172
- GAMMA$172
- T2$161
- HOFFMANN$161
- AQUAMANTYS$153
- TRIATHLON$125
- Iovera$125
How this compares
$10,100 in reported general payments places this provider in the 70th percentile of 273 orthopaedic surgery providers in Connecticut.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Diclofenac Sodium | 99 | $741 |
| Celecoxib | 26 | $350 |
| Meloxicam | 112 | $341 |
| Gabapentin | 15 | $87 |
| Oxycodone Hcl | 22 | $81 |
| Duloxetine Hcl | 16 | $62 |
| Tramadol Hcl | 11 | $33 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Fairfield
- Robert StantonFairfield$199K
- John AwadFairfield$65K
- Peter WhangNew Haven$2M
- James YueShelton$1.8M
- Paul SethiGreenwich$1.6M
- Robert DeveneyDanbury$907K
- Isaac MossFarmington$783K
- James PaceFarmington$721K
- John KeggiMiddlebury$380K
- Sean EsmendeGlastonbury$363K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.